接受长期玻璃体腔抗血管内皮生长因子治疗的1型新生血管性年龄相关性黄斑变性患眼黄斑萎缩进展:光学相干断层扫描血管成像分析
回顾性分析27眼1型新生血管性年龄相关性黄斑变性伴视网膜色素上皮脱离、接受长期抗血管内皮生长因子治疗≥12个月。黄斑萎缩更多呈偏心于色素上皮脱离分布(59.3% vs 11.1%),最终随访时围绕纤维血管性色素上皮脱离的萎缩面积大于覆盖其上的面积(平均3.326 mm vs 0.542 mm,P=0.0118)。OCT血管成像显示萎缩偏心于1型新生血管复合体分布,平均进展速率1.04 mm/年(SD 0.938)。
要点
- 长期抗VEGF治疗的1型新生血管性年龄相关性黄斑变性患眼黄斑萎缩多呈偏心于视网膜色素上皮脱离分布。
- 最终随访时围绕纤维血管性色素上皮脱离的萎缩面积大于覆盖其上的面积(3.326 mm vs 0.542 mm,P=0.0118)。
- OCT血管成像显示萎缩偏心于1型新生血管复合体(4.345 mm vs 1.652 mm,P=0.0465),平均进展速率1.04 mm/年。
核心结论
- 长期抗血管内皮生长因子治疗的1型新生血管性年龄相关性黄斑变性患眼,黄斑萎缩倾向于主要发生于视网膜色素上皮脱离和OCT血管成像所示新生血管血流的偏心区域。
- 慢性血管内皮生长因子抑制下,1型新生血管可能演变为多层视网膜色素上皮脱离,可能对覆盖其上的视网膜色素上皮和外层视网膜提供保护作用。
研究设计与样本
- 回顾性病例系列分析,纳入27眼(27例患者)1型新生血管性年龄相关性黄斑变性伴视网膜色素上皮脱离,随访至少12个月。
- 收集基线及最终随访的人口学信息和视力,每6个月分析频域光学相干断层扫描和近红外反射成像以检测和测量黄斑萎缩。
- 使用Heidelberg软件工具测量黄斑萎缩的位置和面积(平方毫米),并用OCT血管成像共定位1型新生血管血流区域与萎缩位置。
主要发现
- 27眼(27例患者)纳入分析,中位视力20/50,平均年龄82.7岁,平均注射次数29.5次。
- 频域光学相干断层扫描和近红外成像测量显示,59.3%的患眼萎缩主要呈偏心于色素上皮脱离分布,11.1%主要覆盖于色素上皮脱离之上。
- 最终随访时,围绕纤维血管性色素上皮脱离的萎缩面积(平均3.326 mm)大于覆盖其上的面积(平均0.542 mm),差异有统计学意义(P=0.0118)。
- 11眼行En-face OCT图像与OCT血管成像叠加,其中9眼识别为萎缩主要呈偏心模式。
- 此方法显示,主要覆盖于1型新生血管的萎缩平均面积为1.652 mm(范围0-10.464 mm),而主要偏心于新生血管复合体的萎缩面积为4.345 mm(范围0.705-13.758 mm),差异有统计学意义(P=0.0465)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the size and location of macular atrophy in eyes with Type-1 neovascularization (NV) and age-related macular degeneration receiving chronic intravitreal anti-vascular endothelial growth factor therapy. METHODS: A retrospective review of a case series of 27 eyes with Type-1 NV and retinal pigment epithelial detachment (PED) having a minimum of 12 months follow-up was performed. Demographic information and visual acuity at baseline and the final follow-up were collected. Spectral-domain optical coherence tomography (OCT) and near-infrared reflectance were analyzed at 6-month intervals to detect and measure macular atrophy. Location and area (in square millimeter) of macular atrophy were measured using Heidelberg software tools. Also, OCT angiography was used to colocalize the area of Type-1 NV flow versus the location of atrophy. RESULTS: Twenty-seven eyes of 27 patients were included in this analysis. The median visual acuity was 20/50, mean age was 82.7 years, and mean number of injections was 29.5. A larger percentage of eyes (59.3%) developed atrophy predominantly eccentric to the PED versus predominantly overlying the PED (11.1%) when measured with spectral-domain OCT and near-infrared imaging. At the final follow-up, there was a larger area of atrophy surrounding the fibrovascular PED (mean, 3.326 mm) than overlying it (mean, 0.542 mm), and this was statistically significant (P = 0.0118). En-face OCT images were overlaid with OCT angiography in 11 eyes, and a predominantly eccentric pattern of atrophy was identified in 9 of 11 eyes. Using this method, the mean area of atrophy predominantly overlying the Type-1 NV was 1.652 mm (range of 0-10.464 mm), whereas the area of atrophy predominantly eccentric to the neovascular complex was 4.345 mm (range of 0.705-13.758 mm), and this was statistically significant (P = 0.0465). The average rate of atrophy progression was 1.04 mm/year (SD 0.938). CONCLUSION: With long-term anti-vascular endothelial growth factor therapy for eyes with Type-1 NV secondary to age-related macular degeneration, macular atrophy tends to develop predominantly eccentric to the PED and the neovascular flow imaged on OCT angiography. With chronic vascular endothelial growth factor suppression, Type-1 NV may evolve into a multilayered PED that may confer a protective effect to the overlying retinal pigment epithelium and outer retina.
引用
- Christenbury JG, Phasukkijwatana N, Gilani F, et al. PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: An Optical Coherence Tomographic Angiography Analysis. Retina. 2018. PMID: 28723848. doi:10.1097/IAE.0000000000001766
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。